Philippe Laffont’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-38,052
Closed -$2.84M 87
2022
Q2
$2.84M Hold
38,052
0.03% 77
2022
Q1
$4.87M Sell
38,052
-80,292
-68% -$8.78M 0.04% 55
2021
Q4
$15.9M Sell
118,344
-83,160
-41% -$11.9M 0.07% 63
2021
Q3
$27.5M Sell
201,504
-1,528
-0.8% -$193K 0.11% 58
2021
Q2
$21.7M Buy
203,032
+164,980
+434% +$15.8M 0.08% 62
2021
Q1
$3.42M Hold
38,052
0.02% 62
2020
Q4
$3.52M Sell
38,052
-106,852
-74% -$9.54M 0.01% 74
2020
Q3
$14.9M Sell
144,904
-506,604
-78% -$52.9M 0.08% 58
2020
Q2
$66M Buy
+651,508
New +$58.3M 0.58% 32
2019
Q4
Sell
-1,812,252
Closed -$67.6M 399
2019
Q3
$67.6M Buy
+1,812,252
New +$70.4M 0.58% 32

Other funds holding DXCM

Philippe Laffont's DXCM Position: Q3 2022 in Review

Philippe Laffont sold out of DexCom (DXCM) in Q3 2022, closing a stake of 38,052 shares — an estimated $2.84M sold.

Philippe Laffont first reported a position in DXCM in Q3 2019 and held it in 10 quarters. The position peaked at $67.6M in Q3 2019. 794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

  • Philippe Laffont reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
  • Philippe Laffont sold 38,052 DexCom shares in Q3 2022, an estimated $2.84M.
  • Philippe Laffont first reported a position in DexCom in Q3 2019 and held it in 10 quarters.
  • Philippe Laffont's DexCom position peaked at $67.6M in Q3 2019.
  • 794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Coatue Management's 13F filing for Q3 2022, filed 14 Nov 2022.